The Scripps Research Institute, Department of Cell Biology, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA
* Author for correspondence (e-mail: khahn{at}scripps.edu)
![]() |
Summary |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Key words: Rho family GTPase, Fluorescence resonance energy transfer, Microscopy, Cell motility, Dye, Ratio-imaging
![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
For a long time, the presumed local activity of a given GTPase could be inferred only from the appearance of specific cytoskeletal and adhesive structures. The development of different `pull-down' assays using effector domains that selectively bind to GTP-loaded GTPases enabled measurement of active Rho-family GTPases in cell-lysates. Although quantitation of relative activity became possible, these methods provided no spatial information, and only limited temporal resolution. The clear need for information about the spatio-temporal dynamics of Rho protein activation led to the development of fluorescent probes that allow direct, non-destructive measurement of the nucleotide state of Rho GTPases in individual living cells.
Immunofluorescence experiments or live-cell imaging studies using green fluorescent protein (GFP) fusions of Rho GTPases could not fully elucidate the dynamics of Rho protein signaling. Such studies showed that the pool of Rho proteins sequestered by interaction with guanosine dissociation inhibitor (GDI) in the cytoplasm can translocate to the plasma membrane upon stimulation with growth factors or overexpression of guanosine nucleotide exchange factors (GEF) (Kranenburg et al., 1997; Michaelson et al., 2001
). However, they could not reveal whether membrane localization of a GTPase correlates with GTP loading. This was accomplished using GFP fused to domains from Rho effectors, simple practical probes devised to monitor the location of GTP-loaded GTPases in living cells. Bourne and co-workers used a YFP-tagged CRIB (Cdc42- and Rac-interactive binding motif) domain from p21-activated kinase (PAK) to monitor the location of GTP-bound Rac in neutrophils (Srinivasan et al., 2003
). Similarly, Kim et al. showed that a GFP-tagged CRIB domain from the Wiskott-Aldrich syndrome protein (WASP) is recruited to nascent adherens junctions containing E-cadherin in a calcium switch experiment, which suggests that GTP-loaded Cdc42 is recruited to this location (Kim et al., 2000
). The same GFP-fusion was used to detect activated Cdc42 in fixed cells and showed that active Cdc42 is recruited to the immunological synapse in an antigen-specific manner (Cannon et al., 2001
). An important caveat with such probes, however, is their lack of specificity. The GTPase-binding domain of PAK shows only a threefold difference in affinity for Rac versus Cdc42, and so cannot clearly distinguigh between them (Thompson et al., 1998
). The WASP domain does not discriminate between Cdc42, TcL (Vignal et al., 2000
), Tc10 and RhoT (Abe et al., 2003
). In addition, such GFP fusion proteins are diffusely distributed throughout the cell, which leads to a high background and makes it technically challenging to observe accumulation of the probe at discrete locations in some important cases.
![]() |
Bimolecular FRET-based probe for Rac |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
|
Since the acceptor and donor fluorophores are on separate proteins that may have different subcellular distributions, quantitation of FRET is complicated because of contributions of donor emission `bleedthrough' and direct excitation of the acceptor fluorophore to the FRET image. A fraction of these contributions have therefore to be substracted from the raw FRET image, and this will depend on the specific filters used and must be quantitated for each imaging system (Chamberlain et al., 2000). Since this probe does not reveal activation of the endogenous GTPase and requires ectopic expression of GFP-Rac, an obvious experimental restriction is that the amount of probe has to be tightly controlled. Excessive expression of Rac leads to its activation, presumably because there is only a finite amount of GDI to sequester Rac in the cytoplasm. The amount of PBD must also be tightly controlled, since it can exert dominant-negative effects by titrating out the active endogenous GTPase. A similar probe consisting of Rac and PBD fused to GFP variants (CFP and YFP) has also been designed, but the FRET efficiency in this case is lower, because fluorophores embedded in a protein cannot approach each other as closely as free dyes. Although the biosensor based on GFP variants has the important advantage of being genetically encoded, the enhanced sensitivity of the dye-based sensor is valuable for studies of activation of small amounts of Rac in some subcellular locations (Kraynov et al., 2000
).
The ability to detect Rac activation with high spatial resolution has led to valuable biological insights. For example, studies of a wound healing model indicate that there is a gradient of Rac activity that is highest near the leading edge and fades away towards the nucleus. This supports a model in which Rac is activated at the leading edge to promote lamellipodial protrusion (Merlot and Firtel, 2003). In polarized cells, additional hot spots of perinuclear activity have been observed, perhaps corresponding to endomembrane compartments in which activated Rac may regulate vesicle trafficking. As expected, activated Rac is also evident in ruffles induced when quiescent Swiss 3T3 fibroblasts are stimulated with serum. An example is shown in Fig. 1 and illustrates the gain in sensitivity and selectivity achievable by FRET compared with the use of labeled PBD alone. Unlike FRET, simple localization of this effector domain must be discerned over a diffuse background of the same probe. Also, the effector domain interacts with multiple targets, but the FRET signal will be observed only at locations where the effector domain binds to GFP-Rac.
Del Pozo et al. observed that FRET between PBD and the constitutively active V12 mutant of GFP-Rac occurs only in protrusive areas, such as lamellipodia, rather than uniformly over the entire cell (Del Pozo et al., 2002). This is despite the fact that both the constitutively active Rac and the Alexa-labeled PBD were uniformly distributed in their experiments. It is known that GTP-loaded Rac binds to Rho GDI, albeit with lower affinity (Sasaki et al., 1993
) than GDP-loaded Rac. The observation of FRET in only some locations suggested that the GTP-loaded Rac bound to Rho GDI cannot interact with an effector. Using biochemical techniques, Del Pozo et al. clearly showed that Rho GDI and the effector PAK compete in a mutually exclusive fashion for interaction with GTP-loaded Rac. Indeed, mutation of the Rac CAAX box to disrupt the interaction between Rho-GDI and V12 GFP-Rac produced uniform distribution of FRET throughout the cell. The interaction between GTP-loaded Rac and PAK occured around subcellular locations where integrins engage with the extracellular matrix. Integrins therefore appear to activate a signaling pathway that induces dissociation of Rac from Rho-GDI, permitting subsequent membrane translocation of Rac and localized interactions with effectors. Here, use of the Rac FRET probe highlighted a new level of complexity in GTPase signaling, suggesting that GTP loading and membrane recruitment are two events that are controlled separately by distinct signaling pathways. This also showed that the Rac probe does not strictly measure GTP loading but instead reveals the locations where Rac binds to effectors. Note that competition with other molecules that bind to Rac could also eliminate the signal at some subcellular locations.
Another surprise was the difference in the Rac activation patterns of motile fibroblasts in the wound-healing model described above and neutrophils undergoing chemotaxis (Gardiner et al., 2002). When a neutrophil senses a chemoattractant gradient, it extends a lamellipod in which a broad area of Rac activity is observed. Interestingly, at this early time point, additional Rac activity is observed at the retracting tail. As the neutrophil becomes fully polarized, Rac activity at the stably protruding leading edge becomes concentrated into discrete spots that appear and disappear during protrusion. Rac activity in the retracting tail displays a less discrete pattern, but changes in intensity appear to match tail retraction and attachment/detachment to the substratum. The very localized and dynamic changes in Rac activity observed in neutrophils contrast with the broad activity gradient observed in wound healing fibroblasts, possibly owing to the highly motile behaviour of neutrophils. The observation that Rac regulates tail retraction in neutrophils, previously suggested to depend on Rho (Worthylake et al., 2001
), illustrates the value of directly measuring GTPase activity in living cells.
![]() |
Genetically encoded unimolecular FRET probes for Rac, Cdc42 and RhoA |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Such a probe successfully reveals activation of the small GTPase Ras (Mochizuki et al., 2001). Mochizuki et al. fused Ras to a domain from its effector Raf that selectively binds to GTP-loaded Ras, using a short linker, and sandwiched the two domains between CFP and YFP. We refer to this probe design as `GTPase-effector fusion'. High FRET levels are evident when the Raf domain binds to GTP loaded Ras; low FRET levels are evident when Ras is GDP loaded. This probe design imposes significant constraints. Because the C-terminus of Ras is fused to the Raf domain, the CAAX-box that enables farnesylation and subsequent membrane targeting had to be removed from Ras. Farnesylation and plasma membrane attachment was rescued by fusion of the CAAX-box of K-Ras4B to the C-terminus of the whole fusion protein. Since Ras is constitutively membrane anchored, constraining localization to the plasma membrane was acceptable in this case.
Similar probes based on PBD can reveal activation of Rac and Cdc42 (Fig. 2B) (Itoh et al., 2002). Since Rho family GTPases are not constitutively membrane anchored, but can be sequestered in the cytoplasm through their interaction with Rho GDI, moving the native CAAX-box to the C-terminus of the probe produces disadvantages. An intact C-terminus is required on Rho family GTPases, because the interaction between Rho GDI and the GTPase involves both the isoprenoid moiety and the switch I and II domains (Hoffman et al., 2000
). These biosensors therefore ignore regulation provided by Rho GDI, measuring the activation of Rac and Cdc42 only at the plasma membrane. They miss activation patterns on endomembranes, which can be observed with the bimolecular Rac probe. This may be especially significant for Cdc42, which is located mostly on the Golgi, the endoplasmic reticulum and the nuclear envelope rather than on the plasma membrane (Michaelson et al., 2001
). These biosensors do reveal valuable information about localized activation at the plasma membrane. In motile HT1080 cells, the biosensors showed a gradient of both Rac and Cdc42 activation that gradually increases towards the leading edge, and decreases rapidly when cells change direction. Furthermore, they showed that Cdc42 is most active at the tip of the leading edge, whereas Rac activity is highest behind the leading edge.
|
In the same paper, Itoh et al. described an additional FRET probe that consists of the PAK CRIB domain flanked by CFP and YFP (Fig. 2C). We refer to this probe design as `effector domain only'. For this probe, decrease in FRET efficiency produced by binding was explained by structural data showing that the PAK CRIB domain undergoes a dramatic conformational change upon interaction with GTP-loaded Rac or Cdc42 (Hoffman and Cerione, 2000). This may lead to a change in the orientation and/or the distance between CFP and YFP. The biosensor is not sufficiently sensitive to detect activation until it is targeted to the membrane by the CAAX box from K-Ras 4B, revealing activity at the cell's leading edge. It also suffers from lack of specificity (e.g. it does not discriminate between Rac and Cdc42), but has the important advantage that it can respond to regulation by Rho GDI.
Seth et al. adopted the `effector domain only' probe design for the CRIB domain of WASP (Fig. 2C). They observed a decrease in FRET efficiency associated with its binding to GTP-loaded Cdc42, which was again explained by structural data showing a drastic conformational change in the WASP CRIB domain upon binding to Cdc42 (Seth et al., 2003). Taking advantage of the modular structure of the WASP protein, Seth et al. also used Cdc42 and the WASP CRIB domain to construct a biosensor using the `GTPase-effector fusion' probe design. Using spectroscopic techniques, the deactivation kinetics of this probe in response to incubation with a GTPase-activating protein (GAP) were compared with those of recombinant Cdc42 alone in an in vitro system. This led to the important conclusion that, in such probes, the high local concentration of an effector domain can compete against GAP-mediated GTP hydrolysis. This is consistent with structural studies that have shown that GAPs and effectors interact with similar regions on the GTPase (Mott et al., 1999
; Nassar et al., 1998
). Although these different Cdc42 probes display a large change in FRET efficiency in vitro, they cannot measure the activity of endogenous Cdc42 in vivo. Activation can only be seen in living cells upon coexpression of Cdc42 with a GEF or a GAP. Changes in FRET efficiency can then be correlated with in vitro measurements, but subcellular localization of activity cannot be discerned. Such probes could nonetheless be valuable for following the kinetics of total cellular activation, or for high-throughput screening in vitro. Furthermore, none of these probes are membrane-targeted. Therefore, engineering-in a localization motif may render them more sensitive.
An important caveat must be considered when one uses these biosensors in wide-field fluorescence microscopy, rather than in techniques that remove out-of-focus light, such as confocal or deconvolution microscopy. Activated GTPases are localized in membranes. Therefore, in the thick parts of cells, activation can be `diluted' by large volumes of inactive biosensor in the cytoplasm if the probe is soluble. Targeting the probe to the plasma membrane dramatically reduces the amount of cytoplasmic probe, thereby bypassing this `dilution effect' and enabling a higher sensitivity. The important drawback is that access of the probes to some membranes on which the native GTPase is usually found is eliminated. Furthermore, using alternate targeting motifs may localize these probes to sites where upstream regulators are absent.
Yoshizaki et al. recently devised two FRET-based probes to study Rho activity (Yoshizaki et al., 2003). In an effort to build the most reliable probe using the `GTPase-effector fusion' design, Yoshizaki et al. constructed a panel of probes using different Rho effector domains and compared each one containing dominant-positive (Q63L) or wild-type Rho. Most of the probes had similar FRET/CFP ratios, suggesting that the effector domain was effectively competing away GAPs that catalyze hydrolysis of bound GTP. Finally the author picked a probe containing the effector domain from protein kinase N. This displayed a significantly different ratio between dominant positive and wild-type probe, presumably because the PKN domain had a weaker affinity for the GTPase. In order to take into account regulation by GDI, Yoshizaki et al. also used the effector domain from rhotekin to produce a FRET probe that takes advantage of the `effector domain only' design. Again, since the effector domain of rhotekin can bind to GTP-loaded RhoA and RhoC, this probe suffers from the lack of specificity inherent to the design (Reid et al., 1996
). Yoshizaki et al., used these two probes to monitor changes in RhoA activity at the plasma membrane during cell division.
![]() |
A new alternative to FRET |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
All the probes we have described are based on protein domains that bind to a target with a specific conformation. Owing to competition with endogenous ligands, such domains may not always be able to reach their targets, or they may block normal protein interactions. Therefore attaching environmentally sensitive dyes directly to the GTPase, without the need for a separate domain, is also promising. Site-specific labeling of recombinant proteins with dyes remains technically challenging, but given new technologies that enable site-specific incorporation of unnatural amino acids in proteins (Wang et al., 2001), or total synthesis of proteins (Dawson and Kent, 2000
), this is now becoming easier. Taking advantage of the large amount of structural information about Rho family GTPases and their interaction partners, together with the ability to site-specifically label proteins at a desired residue, one can now design probes to sense not only GTP loading but also interactions with specific upstream regulators or downstream effectors.
![]() |
Concluding remarks |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
![]() |
Acknowledgments |
---|
![]() |
References |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Abe, T., Kato, M., Miki, H., Takenawa, T. and Endo, T. (2003). Small GTPase Tc10 and its homologue RhoT induce N-WASP-mediated long process formation and neurite outgrowth. J. Cell Sci. 116, 155-168.
Cannon, J. L., Labno, C. M., Bosco, G., Seth, A., McGavin, M. H., Siminovitch, K. A., Rosen, M. K. and Burkhardt, J. K. (2001). Wasp recruitment to the T cell: APC contact site occurs independently of Cdc42 activation. Immunity 15, 249-259.[Medline]
Chamberlain, C. E., Kraynov, V. S. and Hahn, K. M. (2000). Imaging spatiotemporal dynamics of Rac activation in vivo with FLAIR. Methods Enzymol. 325, 389-400.[CrossRef][Medline]
Dawson, P. E. and Kent, S. B. (2000). Synthesis of native proteins by chemical ligation. Annu. Rev. Biochem. 69, 923-960.[CrossRef][Medline]
Del Pozo, M. A., Kiosses, W. B., Alderson, N. B., Meller, N., Hahn, K. M. and Schwartz, M. A. (2002). Integrins regulate GTP-Rac localized effector interactions through dissociation of Rho-GDI. Nat. Cell Biol. 4, 232-239.[CrossRef][Medline]
Etienne-Manneville, S. and Hall, A. (2002). Rho GTPases in cell biology. Nature 420, 629-635.[CrossRef][Medline]
Gardiner, E. M., Pestonjamasp, K. N., Bohl, B. P., Chamberlain, C., Hahn, K. M. and Bokoch, G. M. (2002). Spatial and temporal analysis of Rac activation during live neutrophil chemotaxis. Curr. Biol. 12, 2029-2034.[CrossRef][Medline]
Hoffman, G. R. and Cerione, R. A. (2000). Flipping the switch: the structural basis for signaling through the CRIB motif. Cell 102, 403-406.[Medline]
Hoffman, G. R., Nassar, N. and Cerione, R. A. (2000). Structure of the Rho family GTP-binding protein Cdc42 in complex with the multifunctional regulator RhoGDI. Cell 100, 345-356.[Medline]
Itoh, R. E., Kurokawa, K., Ohba, Y., Yoshizaki, H., Mochizuki, N. and Matsuda, M. (2002). Activation of rac and cdc42 video imaged by fluorescent resonance energy transfer-based single-molecule probes in the membrane of living cells. Mol. Cell. Biol. 22, 6582-6591.
Kim, S. H., Li, Z. and Sacks, D. B. (2000). E-cadherin-mediated cell-cell attachment activates Cdc42. J. Biol. Chem. 275, 36999-37005.
Kranenburg, O., Poland, M., Gebbink, M., Oomen, L. and Moolenaar, W. H. (1997). Dissociation of LPA-induced cytoskeletal contraction from stress fiber formation by differential localization of RhoA. J. Cell Sci. 110, 2417-2427.
Kraynov, V. S., Chamberlain, C., Bokoch, G. M., Schwartz, M. A., Slabaugh, S. and Hahn, K. M. (2000). Localized Rac activation dynamics visualized in living cells. Science 290, 333-337.
Merlot, S. and Firtel, R. A. (2003). Leading the way: directional sensing through phosphatidylinositol 3-kinase and other signaling pathways. J. Cell Sci. 116, 3471-3478.
Michaelson, D., Silletti, J., Murphy, G., D'Eustachio, P., Rush, M. and Philips, M. R. (2001). Differential localization of Rho GTPases in live cells: regulation by hypervariable regions and RhoGDI binding. J. Cell Biol. 152, 111-126.
Miyawaki, A. (2003). Visualization of the spatial and temporal dynamics of intracellular signaling. Dev. Cell 4, 295-305.[Medline]
Mochizuki, N., Yamashita, S., Kurokawa, K., Ohba, Y., Nagai, T., Miyawaki, A. and Matsuda, M. (2001). Spatio-temporal images of growth-factor-induced activation of Ras and Rap1. Nature 411, 1065-1068.[CrossRef][Medline]
Mott, H. R., Owen, D., Nietlispach, D., Lowe, P. N., Manser, E., Lim, L. and Laue, E. D. (1999). Structure of the small G protein Cdc42 bound to the GTPase-binding domain of ACK. Nature 399, 384-388.[CrossRef][Medline]
Nassar, N., Hoffman, G. R., Manor, D., Clardy, J. C. and Cerione, R. A. (1998). Structures of Cdc42 bound to the active and catalytically compromised forms of Cdc42GAP. Nat. Struct. Biol. 5, 1047-1052.[CrossRef][Medline]
Nimnual, A. S., Taylor, L. J. and Bar-Sagi, D. (2003). Redox-dependent downregulation of Rho by Rac. Nat. Cell Biol. 5, 236-241.[CrossRef][Medline]
Nobes, C. D. and Hall, A. (1995). Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 81, 53-62.[Medline]
Randazzo, P. A., Nie, Z., Miura, K. and Hsu, V. W. (2000). Molecular aspects of the cellular activities of ADP-ribosylation factors. Sci STKE 2000, RE1.
Reid, T., Furuyashiki, T., Ishizaki, T., Watanabe, G., Watanabe, N., Fujisawa, K., Morii, N., Madaule, P. and Narumiya, S. (1996). Rhotekin, a new putative target for Rho bearing homology to a serine/threonine kinase, PKN, and rhophilin in the rho-binding domain. J. Biol. Chem. 271, 13556-13560.
Sasaki, T., Kato, M. and Takai, Y. (1993). Consequences of weak interaction of rho GDI with the GTP-bound forms of rho p21 and rac p21. J. Biol. Chem. 268, 23959-23963.
Seth, A., Otomo, T., Yin, H. L. and Rosen, M. K. (2003). Rational design of genetically encoded fluorescence resonance energy transfer-based sensors of cellular Cdc42 signaling. Biochemistry 42, 3997-4008.[CrossRef][Medline]
Srinivasan, S., Wang, F., Glavas, S., Ott, A., Hofmann, F., Aktories, K., Kalman, D. and Bourne, H. R. (2003). Rac and Cdc42 play distinct roles in regulating PI(3,4,5)P3 and polarity during neutrophil chemotaxis. J. Cell Biol. 160, 375-385.
Thompson, G., Owen, D., Chalk, P. A. and Lowe, P. N. (1998). Delineation of the Cdc42/Rac-binding domain of p21-activated kinase. Biochemistry 37, 7885-7891.[CrossRef][Medline]
Toutchkine, A., Kraynov, V. S. and Hahn, K. M. (2003). Solvent-sensitive dyes to report protein conformational changes in living cells. J. Am. Chem. Soc. 125, 4132-4145.[CrossRef][Medline]
Tsuji, T., Ishizaki, T., Okamoto, M., Higashida, C., Kimura, K., Furuyashiki, T., Arakawa, Y., Birge, R. B., Nakamoto, T., Hirai, H. et al. (2002). ROCK and mDia1 antagonize in Rho-dependent Rac activation in Swiss 3T3 fibroblasts. J. Cell Biol. 157, 819-830.
Vignal, E., de Toledo, M., Comunale, F., Ladopoulou, A., Gauthier-Rouviere, C., Blangy, A. and Fort, P. (2000). Characterization of TCL, a new GTPase of the rho family related to TC10 andCcdc42. J. Biol. Chem. 275, 36457-36464.
Wang, L., Brock, A., Herberich, B. and Schultz, P. G. (2001). Expanding the genetic code of Escherichia coli. Science 292, 498-500.
Worthylake, R. A., Lemoine, S., Watson, J. M. and Burridge, K. (2001). RhoA is required for monocyte tail retraction during transendothelial migration. J. Cell Biol. 154, 147-160.
Yoshizaki, H., Ohba, Y., Kurokawa, K., Itoh, R. E., Nakamura, T., Mochizuki, N., Nagashima, K. and Matsuda, M. (2003). Activity of Rho-family GTPases during cell division as visualized with FRET-based probes. J. Cell Biol. 162, 223-232.
Related articles in JCS: